We found that the overall therapeutic benefits of various treatments were similar to those found in the CT26‐derived CDX model, except that no significant differences in body weight and ascites were observed among various groups (Figure 10b; Figure S13, Supporting Information). The gene discussed is DDX53; the disease is Ascites.